Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
AV8 Ventures is a venture capital firm located in Palo Alto, California, founded to support early-stage startups primarily in the Seed and Series A investment stages. Established with the backing of Allianz, one of the world's largest financial services providers, AV8 Ventures focuses on helping entrepreneurs transform significant markets, particularly in healthcare, enterprise software, financial technology, and deep tech.
The firm manages approximately $360 million in assets under management (AUM) and has a strong commitment to providing not only capital but also strategic guidance throughout the lifecycle of its investments. AV8 Ventures operates from its Palo Alto office and has expanded its reach with an additional location in London, UK.
Since its inception, AV8 Ventures has built a reputation for its hands-on approach to supporting portfolio companies, leveraging its extensive network and industry expertise to help startups navigate challenges and scale effectively. The firm has made notable strides in the venture capital space, consistently backing innovative companies that drive change in their respective industries.
AV8 Ventures invests in early-stage startups across several key sectors, including healthcare, enterprise software, financial technology, and deep tech. The firm primarily engages with companies at the Seed and Series A stages, providing initial check sizes ranging from $1 million to $5 million. This investment strategy allows AV8 Ventures to support entrepreneurs who are innovating in transformative sectors.
The firm emphasizes its commitment to assisting founders by offering not just financial backing but also strategic guidance and access to a global network. AV8 Ventures leverages Allianz's domain expertise in risk management, data, and regulatory compliance to open doors for its portfolio companies. This unique positioning enables the firm to provide valuable insights and resources that help startups thrive in competitive markets.
AV8 Ventures seeks to partner with entrepreneurs who are driving innovation and transformation in their industries. The firm looks for founders who demonstrate a strong vision and the ability to execute their ideas effectively. By focusing on early-stage investments, AV8 Ventures aims to support companies throughout their growth journey, ensuring they have the necessary resources and guidance to succeed.
AV8 Ventures has built a diverse portfolio of innovative companies across various sectors. Notable portfolio companies include:
This portfolio reflects AV8 Ventures' commitment to supporting transformative technologies that address critical challenges in healthcare, enterprise, and financial services.
George Ugras — Managing Director / GP; previously worked at IBM Ventures and Apax Partners, specializing in technology investments.
Ruchita Sinha — Partner; focuses on healthcare investments, bringing expertise in medical technology and innovation.
Shawn Kung — Partner; specializes in enterprise software, with a background in scaling SaaS companies.
Brett Battles — Partner; focuses on product development and go-to-market strategies, with experience in launching successful startups.
Serpil Kuyucak — Operating Partner; brings expertise in finance and compliance, ensuring portfolio companies meet regulatory standards.
To pitch AV8 Ventures, founders should reach out via email at info@av8.vc or through their website at av8.vc. A comprehensive pitch deck is essential, including details about the startup's business model, market opportunity, and team qualifications.
AV8 Ventures prefers to receive pitches through warm introductions, but cold outreach is also accepted. Founders can expect a response within a few weeks, depending on the volume of inquiries.
In January 2026, AV8 Ventures co-led a $17 million seed round for Think Bioscience, a company focused on healthcare innovations. This investment highlights the firm's ongoing commitment to supporting transformative technologies in the healthcare sector.
AV8 Ventures recently announced the launch of its €150 million Fund II, backed by Allianz, which aims to target investments in fintech, digital health, and enterprise solutions. This fund reinforces the firm's strategy of leveraging Allianz's expertise to support portfolio companies.
What are AV8 Ventures' investment criteria?
AV8 Ventures focuses on early-stage startups in healthcare, enterprise software, financial technology, and deep tech. The firm typically invests in Seed and Series A stages, with check sizes ranging from $1 million to $5 million.
How can I pitch to AV8 Ventures?
Founders can pitch AV8 Ventures by visiting their website at av8.vc and using the contact email info@av8.vc. A well-prepared pitch deck should include details about the business model, market opportunity, and team background.
What makes AV8 Ventures different from other VCs?
AV8 Ventures differentiates itself by leveraging Allianz's expertise in risk management, data, and regulatory compliance. This strategic partnership allows the firm to provide unique insights and resources to its portfolio companies.
What is the geographic focus of AV8 Ventures?
The firm primarily invests in startups based in North America, particularly those located in significant innovation hubs.
What kind of post-investment support does AV8 Ventures provide?
AV8 Ventures offers strategic guidance, access to a global network, and co-investment opportunities with top-tier firms. The firm is actively involved in helping portfolio companies navigate challenges and scale their businesses effectively.
What is the size of AV8 Ventures' funds?
AV8 Ventures manages approximately $360 million in assets under management, with a confirmed Fund II of €150 million backed by Allianz.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.